Details of the Drug Formulations

General Information of Drug (ID: DM6FG1P)

Drug Name
Doxercalciferol Drug Info
Synonyms
Doxcercalciferol; Hectorol; Doxercalciferol [INN]; TSA 840; BCI-101; Doxercalciferol (INN); Hectorol (TN); (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol; (5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraene-1alpha,3beta-diol; 1-Hydroxyergocalciferol; 1-alpha-Hydroxyvitamin D2; 1alpha-Hydroxyergocalciferol; 1alpha-OH-D2; 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol,(1-alpha,3-beta,5Z,7E,22E)
Indication
Disease Entry ICD 11 Status REF
Chronic kidney disease GB61 Approved [1]
Cross-matching ID
PubChem CID
5281107
ChEBI ID
CHEBI:4712
CAS Number
54573-75-0
TTD ID
D0G5CF
INTEDE ID
DR1757
ACDINA ID
D00214

Full List of Drug Formulations Containing This Drug

Doxercalciferol 0.0005 mg capsule
Company Formulation ID FDA Description
American Health Packaging F06804 D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Isopropyl alcohol; Ammonia; Butylated hydroxyanisole; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Medium-chain triglycerides; Alcohol; Gelatin; Shellac
West-Ward Pharmaceticals F06805 D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Isopropyl alcohol; Ammonia; Butylated hydroxyanisole; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Medium-chain triglycerides; Alcohol; Gelatin; Shellac
Rising Pharmaceuticals; Winthrop F06806 Fd&c red no. 40; Butylated hydroxyanisole; Ferric oxide yellow; Glycerin; Titanium dioxide; Medium-chain triglycerides; Alcohol; Gelatin, unspecified
------------------------------------------------------------------------------------
Doxercalciferol 0.001 mg capsule
Company Formulation ID FDA Description
West-Ward Pharmaceticals F06807 Butyl alcohol; Fd&c yellow no. 6; Isopropyl alcohol; Ammonia; Butylated hydroxyanisole; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Medium-chain triglycerides; Alcohol; Gelatin; Shellac
Rising Pharmaceuticals; Winthrop F06808 Fd&c yellow no. 6; Butylated hydroxyanisole; Glycerin; Titanium dioxide; Medium-chain triglycerides; Alcohol; Gelatin, unspecified
------------------------------------------------------------------------------------
Doxercalciferol 0.0025 mg capsule
Company Formulation ID FDA Description
West-Ward Pharmaceticals F06809 D&c yellow no. 10; Butyl alcohol; Isopropyl alcohol; Ammonia; Butylated hydroxyanisole; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Water; Medium-chain triglycerides; Alcohol; Gelatin; Shellac
Rising Pharmaceuticals; Winthrop F06810 Butylated hydroxyanisole; Ferric oxide yellow; Glycerin; Titanium dioxide; Medium-chain triglycerides; Alcohol; Gelatin, unspecified
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2790).